Theres a major shift toward using medications like Ozempic, Wegovy, and Mounjaro as part of weight management, which is propelling the F&B industry to innovate in different ways to meet the unique needs of GLP-1 users
DOI: 10.1097/MED.0000000000000190
A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain
Support GLP-1: Promote your body's GLP-1 production, reduce hunger and cravings and support healthy weight management with 3 clinically-studied plant ingredients
COVID patients and controls were excluded if they had a lifetime history of psychiatric axis-1 disorders, including major affective disorders such as major depression and bipolar disorder, dysthymia, GAD and panic disorder, schizo-affective disorder, schizophrenia, psycho-organic syndrome, and substance use disorders, except tobacco use disorder (TUD)
105, S117S314